Sep 26, 2025· Comment from Alliance for Pharmacy Compounding and National Community Pharmacists Association· FDA-2025-N-2589-2795
Comment from the Alliance for Pharmacy Compounding and the National Community Pharmacists Association
FDANonrulemakingFDA-2025-N-2589
FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women
RIN
—
Last modified
Sep 26, 2025
Comment window
closed 307d ago
National Community Pharmacists Association filings
1
Activity
National Community Pharmacists Association filed 1 comment on this docket between Sep 26, 2025 and Sep 26, 2025. 0 other organizations filed here. The comment window closed 307d ago.
What National Community Pharmacists Association filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (0)
See everyone who commented →- National Community Pharmacists AssociationTHIS ORG1 filing · confidence 97%